Your browser doesn't support javascript.
loading
Commentary: A prospective, randomized, parallel group, double blind, multicenter study to compare the efficacy, safety and immunogenicity of Lupin's ranibizumab with lucentis in patients with neovascular age-related macular degeneration.
Gopal, Lingam.
Affiliation
  • Gopal L; National University Hospital; National University of Singapore, Singapore.
Indian J Ophthalmol ; 70(8): 3014-3015, 2022 08.
Article in En | MEDLINE | ID: mdl-35918963
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Wet Macular Degeneration / Macular Degeneration Type of study: Clinical_trials / Diagnostic_studies / Observational_studies Limits: Humans Language: En Journal: Indian J Ophthalmol Year: 2022 Document type: Article Affiliation country: Singapur Country of publication: India
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Wet Macular Degeneration / Macular Degeneration Type of study: Clinical_trials / Diagnostic_studies / Observational_studies Limits: Humans Language: En Journal: Indian J Ophthalmol Year: 2022 Document type: Article Affiliation country: Singapur Country of publication: India